Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

11289	Companies
250813	Keywords
179546	Articles
136607	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 08/10/2026 at 07:00, 2 months 26 days ago

BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Biophytis secures approval from ANVISA for OBA clinical trial in Brazil, advancing BIO101 drug candidate for obesity treatment. Key milestone in multinational clinical development

Biophytis Obesity Treatment OBA Clinical Trial ANVISA Approval BIO101 Drug Candidate
BRIEF

published on 08/03/2026 at 07:05, 3 months 2 days ago

Biophytis Updates on Hong Kong Joint Venture Progress

Biophytis Joint Venture Clinical Trial Sarcopenia BIO101
REGULATED PRESS RELEASE

published on 08/03/2026 at 07:00, 3 months 2 days ago

BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Biophytis provides an update on its Hong Kong joint venture, including intellectual property transfer, funding details, and clinical trial preparations

Biophytis Joint Venture Hong Kong Intellectual Property Clinical Trial
PRESS RELEASE

published on 08/03/2026 at 06:59, 3 months 2 days ago

BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Biophytis provides an update on its Hong Kong joint venture, including key milestones achieved and imminent progress. The joint venture aims to develop BIO101 for sarcopenia in Asian markets

Biophytis Joint Venture Hong Kong Sarcopenia BIO101
BRIEF

published on 07/29/2026 at 23:05, 3 months 6 days ago

Biophytis Reports Audited 2025 Financial Results and Stock Trading Resumption

Financial Results Biophytis Trading Resumption 2025 Audit Funding Uncertainty
REGULATED PRESS RELEASE

published on 07/29/2026 at 23:00, 3 months 6 days ago

BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Biophytis announces the auditing of its 2025 financial statements and the resumption of trading in its stock. The company's financial debt and current liabilities decreased by 5% compared to 2024

Financial Statements Biophytis Financial Debt Trading Resumption Liabilities
PRESS RELEASE

published on 07/29/2026 at 22:59, 3 months 6 days ago

BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Biophytis announces the auditing of its 2025 financial statements and the resumption of trading in its stock. The company's financial debt and current liabilities decreased by 5% in 2025. Net loss improved by 13% compared to 2024

Financial Statements Biophytis Trading Net Loss Financial Debt
BRIEF

published on 07/01/2026 at 07:05, 4 months 4 days ago

Biophytis Reports 2025 Financial Outcomes and Strategic Plans

Regulatory Milestones Asian Joint Venture Biophytis Financial Results Sarcopenia Clinical Trials Cash Flow Uncertainty
REGULATED PRESS RELEASE

published on 07/01/2026 at 07:00, 4 months 4 days ago

BIOPHYTIS REPORTS ITS PROVISIONAL FINANCIAL RESULTS AND PROVIDES ITS STRATEGIC OUTLOOK
Biophytis reports provisional financial results for fiscal year 2025 and strategic outlook, including milestones in sarcopenia and obesity programs, engagement with scientific community, and financial restructuring

Biophytis Sarcopenia Obesity Strategic Outlook Provisional Financial Results
BRIEF

published on 06/15/2026 at 23:05, 4 months 19 days ago

Biophytis Temporarily Suspends Share Trading

Biophytis Financial Report Euronext Growth Share Suspension Operational Delay

Accesswire

Published on 11/05/2026 at 15:20, 1 hour 37 minutes ago

MicroVision and LAKE FUSION Technologies Sign Multi-Year Strategic Partnership Agreement for IRIS(TM) Lidar Sensors
Published on 11/05/2026 at 14:31, 2 hours 26 minutes ago

First Breach Close-Quarters Strike (CQS) Drone Successfully Completes Full Mission Profile
Published on 11/05/2026 at 14:25, 2 hours 32 minutes ago

Polaris Renewable Energy Announces Q3 2026 Results
Published on 11/05/2026 at 14:20, 2 hours 37 minutes ago

Polaris Renewable Energy Declares Quarterly Dividend
Published on 11/05/2026 at 14:15, 2 hours 42 minutes ago

Loar Holdings Inc. Reports Q3 2026 Record Results and Upward Revision to 2026 Outlook and Full Year 2027 Outlook

View all ACCESSWIRE

EQS Group

Published on 11/05/2026 at 16:45, 12 minutes ago

Ondo Finance Becomes World's Largest Tokenization Platform
Published on 11/05/2026 at 15:55, 1 hour 2 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 11/05/2026 at 15:34, 1 hour 23 minutes ago

Finexity AG: NuWays and GBC confirm price targets following Capital Markets Day and 9-month figures, taking the share split into account
Published on 11/05/2026 at 15:10, 1 hour 47 minutes ago

Center for Creative Leadership Names Patrick Mullane President and Chief Executive Officer
Published on 11/05/2026 at 14:58, 1 hour 59 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

Les Echos

Published on 11/05/2026 at 10:16, 6 hours 41 minutes ago

Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
Published on 11/05/2026 at 07:44, 9 hours 13 minutes ago

ENGIE 9M 2026 results
Published on 11/05/2026 at 07:00, 9 hours 57 minutes ago

Eurazeo’s European asset management platform continues to gain momentum, driven by sustained international fundraising
Published on 11/05/2026 at 07:00, 9 hours 57 minutes ago

Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
Published on 11/04/2026 at 18:00, 22 hours 57 minutes ago

The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026

View all LES ECHOS COMFI WIRE